Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
McGettigan P, Henry D. McGettigan P, et al. JAMA. 2006 Oct 4;296(13):1633-44. doi: 10.1001/jama.296.13.jrv60011. Epub 2006 Sep 12. JAMA. 2006. PMID: 16968831 Review.
Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
Schjerning Olsen AM, Lindhardsen J, Gislason GH, McGettigan P, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C, Lamberts M. Schjerning Olsen AM, et al. Among authors: mcgettigan p. BMJ. 2015 Oct 19;351:h5096. doi: 10.1136/bmj.h5096. BMJ. 2015. PMID: 26481405 Free PMC article.
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM, Gislason GH, McGettigan P, Fosbøl E, Sørensen R, Hansen ML, Køber L, Torp-Pedersen C, Lamberts M. Schjerning Olsen AM, et al. Among authors: mcgettigan p. JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809. JAMA. 2015. PMID: 25710657
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
McGettigan P, Henry D. McGettigan P, et al. PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27. PLoS Med. 2011. PMID: 21980265 Free PMC article. Review.
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.
McGettigan P, Han P, Jones L, Whitaker D, Henry D. McGettigan P, et al. Br J Clin Pharmacol. 2008 Jun;65(6):927-34. doi: 10.1111/j.1365-2125.2008.03121.x. Epub 2008 Apr 1. Br J Clin Pharmacol. 2008. PMID: 18384446 Free PMC article.
Response rates and representativeness: a lottery incentive improves physician survey return rates.
Robertson J, Walkom EJ, McGettigan P. Robertson J, et al. Among authors: mcgettigan p. Pharmacoepidemiol Drug Saf. 2005 Aug;14(8):571-7. doi: 10.1002/pds.1126. Pharmacoepidemiol Drug Saf. 2005. PMID: 15937989 Clinical Trial.
Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships.
McGettigan P, Han P, Henry D. McGettigan P, et al. Br J Clin Pharmacol. 2006 Sep;62(3):358-65. doi: 10.1111/j.1365-2125.2006.02660.x. Br J Clin Pharmacol. 2006. PMID: 16934052 Free PMC article.
Upper gastrointestinal event risk with COX-2 inhibitors depended on known risk factors.
Henry D, McGettigan P. Henry D, et al. Among authors: mcgettigan p. ACP J Club. 2003 Mar-Apr;138(2):51. ACP J Club. 2003. PMID: 12614136 No abstract available.
Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs.
Henry D, McGettigan P. Henry D, et al. Among authors: mcgettigan p. Int J Clin Pract Suppl. 2003 Apr;(135):43-9. Int J Clin Pract Suppl. 2003. PMID: 12723747 Review.
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene.
McGettigan P, Lincz LF, Attia J, McElduff P, Bissett L, Peel R, Stokes B, Hancock S, Henderson K, Seldon M, Henry D. McGettigan P, et al. Br J Clin Pharmacol. 2011 Oct;72(4):707-14. doi: 10.1111/j.1365-2125.2011.03957.x. Br J Clin Pharmacol. 2011. PMID: 21371074 Free PMC article.
114 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback